Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
about
Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environmentComparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.Interferon-gamma is produced by CD8+ T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus lossRelation between viral fitness and immune escape within the hepatitis C virus proteaseHepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus controlGenetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses.Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunity.Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice.Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune responsePrediction of T-cell epitopes of hepatitis C virus genotype 5aThe level of viral antigen presented by hepatocytes influences CD8 T-cell function.Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis CDevelopment of prophylactic and therapeutic vaccines against hepatitis C virus.Hepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains.Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.Hepatitis C virus (HCV): a review of immunological aspects.CCL5: a double-edged sword in host defense against the hepatitis C virus.Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction.Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b(+) HLA-A24(+) patients.Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial).
P2860
Q26775018-D8CBB84B-1C0C-4B13-AD7B-A26A3FE46F31Q27472916-30BFE605-3263-460B-A128-C26D886A5ED6Q27478124-9EB99844-C437-4EA6-A41E-DB528F81CF20Q27478333-85852294-C15E-4866-9FAD-09E8DA31EC26Q28082128-B5756D7B-EDD2-4A62-BB88-E9997146E408Q31112300-C52A9653-751E-4ABD-831D-ACEB234A4632Q33282312-7624F078-FB36-4F06-A797-F53CDB51C830Q33713956-72EDF83D-6C2A-41B9-908E-A75E7C5C7A64Q34546149-1CAD1650-4801-4A38-9F3E-CD5AF17AAA15Q34552781-9B635CCE-2D85-4B95-BF63-240EF87AD4DBQ34896702-7B580DA8-5F51-46E3-B117-B51C3AF821CCQ35784981-8F9F4493-16D6-456A-B4D0-AD87547BC251Q36178690-EBAA82DE-09C6-4AB8-B186-00E1198DDF7CQ36198667-D4238523-587C-4FA7-8EE9-BA2600EF5D82Q36606741-E888D2DA-C9E6-421E-96F7-3A0658C26830Q36980759-98AF7B28-B703-444C-85B4-45C14678E145Q37344238-4FA5B950-16E3-4235-A44E-96BC239B0413Q37952808-6A93ED20-2081-41DE-9754-0797FAA33213Q39860495-01B95812-6930-496C-B924-DD19A8A53956Q42986524-F17703A9-4137-40AB-96F5-4B2F402757D3Q44521320-6ADFF504-B206-4860-916F-5E4F2DF6F01AQ47375197-E3ED69EB-79FA-4C11-B4E4-2257A1C64825
P2860
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Effect of interferon-alpha the ...... C virus-infected individuals.
@en
type
label
Effect of interferon-alpha the ...... C virus-infected individuals.
@en
prefLabel
Effect of interferon-alpha the ...... C virus-infected individuals.
@en
P2093
P2860
P1476
Effect of interferon-alpha the ...... C virus-infected individuals.
@en
P2093
Alessandro Canella
Cinzia Fortini
Fabiola Micheletti
Guido Gualandi
Martina Bazzaro
Mauro Marastoni
Michele Marino
Roberto Tomatis
Serena Traniello
Simona Vertuani
P2860
P304
P356
10.1002/1521-4141(200201)32:1<144::AID-IMMU144>3.0.CO;2-X
P407
P577
2002-01-01T00:00:00Z